25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

GeneMatrix Inc
Buy, Hold or Sell?

Let's analyze Genematrix together

I guess you are interested in GeneMatrix Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of GeneMatrix Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about GeneMatrix Inc

I send you an email if I find something interesting about GeneMatrix Inc.

1. Quick Overview

1.1. Quick analysis of Genematrix (30 sec.)










1.2. What can you expect buying and holding a share of Genematrix? (30 sec.)

How much money do you get?

How much money do you get?
₩0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
₩998.97
Expected worth in 1 year
₩887.48
How sure are you?
32.5%

+ What do you gain per year?

Total Gains per Share
₩-111.49
Return On Investment
-4.0%

For what price can you sell your share?

Current Price per Share
₩2,785.00
Expected price per share
₩2,585 - ₩4,295
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Genematrix (5 min.)




Live pricePrice per Share (EOD)
₩2,785.00

2.2. Growth of Genematrix (5 min.)




Is Genematrix growing?

Current yearPrevious yearGrowGrow %
How rich?$13.9m$16.9m-$1.5m-10.1%

How much money is Genematrix making?

Current yearPrevious yearGrowGrow %
Making money-$348.6k-$1m$677k194.2%
Net Profit Margin-24.6%-67.2%--

How much money comes from the company's main activities?

2.3. Financial Health of Genematrix (5 min.)




2.4. Comparing to competitors in the Diagnostics & Research industry (5 min.)




  Industry Rankings (Diagnostics & Research)  

3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Genematrix?

Welcome investor! Genematrix's management wants to use your money to grow the business. In return you get a share of Genematrix.

First you should know what it really means to hold a share of Genematrix. And how you can make/lose money.

Speculation

The Price per Share of Genematrix is ₩2,785. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Genematrix.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Genematrix, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ₩998.97. Based on the TTM, the Book Value Change Per Share is ₩-27.87 per quarter. Based on the YOY, the Book Value Change Per Share is ₩-73.50 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ₩0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Genematrix.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 % of Price per Share% of Price per Share% of Price per Share% of Price per Share% of Price per Share
Usd Eps-0.040.0%-0.020.0%-0.050.0%-0.010.0%-0.010.0%
Usd Book Value Change Per Share-0.050.0%-0.020.0%-0.050.0%0.010.0%0.010.0%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.050.0%-0.020.0%-0.050.0%0.010.0%0.010.0%
Usd Price Per Share1.74-2.00-2.80-5.42-4.18-
Price to Earnings Ratio-9.82--21.85--18.36-6.39--6.25-
Price-to-Total Gains Ratio-36.66--51.82--73.14--95.60--58.50-
Price to Book Ratio2.49-2.59-3.30-5.75-6.55-
Price-to-Total Gains Ratio-36.66--51.82--73.14--95.60--58.50-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share1.9495
Number of shares512
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.020.01
Usd Total Gains Per Share-0.020.01
Gains per Quarter (512 shares)-9.994.55
Gains per Year (512 shares)-39.9618.20
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-40-500188
20-80-9003626
30-120-13005544
40-160-17007362
50-200-21009180
60-240-250010998
70-280-2900127116
80-320-3300146134
90-360-3700164152
100-400-4100182170

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.03.00.025.0%1.011.00.08.3%8.012.00.040.0%8.021.011.020.0%8.021.017.017.4%
Book Value Change Per Share1.03.00.025.0%1.011.00.08.3%8.012.00.040.0%13.027.00.032.5%14.032.00.030.4%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.040.00.0%0.00.046.00.0%
Total Gains per Share1.03.00.025.0%1.011.00.08.3%8.012.00.040.0%13.027.00.032.5%14.032.00.030.4%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of GeneMatrix Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---67.921-27.873-59%-73.500+8%12.692-635%9.713-799%
Book Value Per Share--998.9671100.373-9%1211.770-18%1283.668-22%935.210+7%
Current Ratio--4.0864.068+0%4.370-6%3.809+7%2.506+63%
Debt To Asset Ratio--0.3020.281+8%0.238+27%0.247+22%0.344-12%
Debt To Equity Ratio--0.4330.391+11%0.313+38%0.359+21%0.663-35%
Dividend Per Share----0%-0%-0%-0%
Eps---63.367-24.950-61%-73.394+16%-13.121-79%-13.239-79%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%0.725+38%
Market Cap55600297000.000+11%49710858000.00056972835750.000-13%79981576250.000-38%154552854300.000-68%119101427497.584-58%
Net Profit Margin---0.428-0.246-42%-0.672+57%-0.143-67%-0.182-58%
Operating Margin----0%-0%-0.0230%-0.1220%
Operating Ratio--0.8671.520-43%1.440-40%0.945-8%1.096-21%
Pb Ratio2.788+11%2.4932.591-4%3.301-24%5.747-57%6.554-62%
Pe Ratio-10.988-12%-9.824-21.849+122%-18.358+87%6.390-254%-6.251-36%
Price Per Share2785.000+11%2490.0002853.750-13%4006.250-38%7741.500-68%5965.750-58%
Price To Free Cash Flow Ratio---34.614-100%-59.3280%-128.9680%302.419-100%
Price To Total Gains Ratio-41.004-12%-36.660-51.819+41%-73.143+100%-95.599+161%-58.498+60%
Quick Ratio---2.098-100%2.493-100%2.842-100%1.895-100%
Return On Assets---0.044-0.018-59%-0.046+5%-0.008-82%-0.009-79%
Return On Equity---0.063-0.026-60%-0.061-4%-0.012-82%-0.018-72%
Total Gains Per Share---67.921-27.873-59%-73.500+8%12.692-635%9.713-799%
Usd Book Value--13960510.20015377651.230-9%16934406.953-18%17939179.481-22%13069502.177+7%
Usd Book Value Change Per Share---0.048-0.020-59%-0.051+8%0.009-635%0.007-799%
Usd Book Value Per Share--0.6990.770-9%0.848-18%0.899-22%0.655+7%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.044-0.017-61%-0.051+16%-0.009-79%-0.009-79%
Usd Free Cash Flow----177774.3170%-447696.3030%311787.165-100%55796.469-100%
Usd Market Cap38920207.900+11%34797600.60039880985.025-13%55987103.375-38%108186998.010-68%83370999.248-58%
Usd Price Per Share1.950+11%1.7431.998-13%2.804-38%5.419-68%4.176-58%
Usd Profit---885554.600-348669.010-61%-1025682.455+16%-183359.078-79%-185007.363-79%
Usd Revenue--2068973.9001763249.247+17%1490212.509+39%1975239.188+5%1445733.051+43%
Usd Total Gains Per Share---0.048-0.020-59%-0.051+8%0.009-635%0.007-799%
 EOD+4 -3MRQTTM+7 -20YOY+14 -125Y+7 -2010Y+14 -15

3.3 Fundamental Score

Let's check the fundamental score of GeneMatrix Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-10.988
Price to Book Ratio (EOD)Between0-12.788
Net Profit Margin (MRQ)Greater than0-0.428
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.000
Current Ratio (MRQ)Greater than14.086
Debt to Asset Ratio (MRQ)Less than10.302
Debt to Equity Ratio (MRQ)Less than10.433
Return on Equity (MRQ)Greater than0.15-0.063
Return on Assets (MRQ)Greater than0.05-0.044
Total3/10 (30.0%)

3.4 Technical Score

Let's check the technical score of GeneMatrix Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5039.069
Ma 20Greater thanMa 503,040.000
Ma 50Greater thanMa 1003,216.800
Ma 100Greater thanMa 2003,190.900
OpenGreater thanClose2,850.000
Total3/5 (60.0%)

4. In-depth Analysis

4.1 About GeneMatrix Inc

GeneMatrix Inc. develops diagnostic products for various diseases in the field of molecular diagnostics. The company offers products for hepatitis B, hepatitis C, cervical cancer, sexually transmitted infections, respiratory infections, and gastrointestinal infections; vaccines for preventing various diseases; and new natural pharmaceutical materials for health enhancement and treatment. It also provides biochemical diagnostics, such as special chemistry and general chemistry, that includes semi and full auto analyer, and calibrators and controls. The company was founded in 2000 and is headquartered in Seongnam, South Korea.

Fundamental data was last updated by Penke on 2024-11-19 00:55:05.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is fair priced.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Genematrix earns for each ₩1 of revenue.

  • Above 10% is considered healthy but always compare Genematrix to the Diagnostics & Research industry mean.
  • A Net Profit Margin of -42.8% means that ₩-0.43 for each ₩1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of GeneMatrix Inc:

  • The MRQ is -42.8%. The company is making a huge loss. -2
  • The TTM is -24.6%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-42.8%TTM-24.6%-18.2%
TTM-24.6%YOY-67.2%+42.6%
TTM-24.6%5Y-14.3%-10.3%
5Y-14.3%10Y-18.2%+3.9%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ-42.8%-5.6%-37.2%
TTM-24.6%-8.8%-15.8%
YOY-67.2%-0.8%-66.4%
5Y-14.3%-1.9%-12.4%
10Y-18.2%-0.3%-17.9%
4.3.1.2. Return on Assets

Shows how efficient Genematrix is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Genematrix to the Diagnostics & Research industry mean.
  • -4.4% Return on Assets means that Genematrix generated ₩-0.04 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of GeneMatrix Inc:

  • The MRQ is -4.4%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -1.8%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-4.4%TTM-1.8%-2.6%
TTM-1.8%YOY-4.6%+2.8%
TTM-1.8%5Y-0.8%-1.0%
5Y-0.8%10Y-0.9%+0.1%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ-4.4%-1.2%-3.2%
TTM-1.8%-2.1%+0.3%
YOY-4.6%-0.9%-3.7%
5Y-0.8%-0.1%-0.7%
10Y-0.9%-0.5%-0.4%
4.3.1.3. Return on Equity

Shows how efficient Genematrix is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Genematrix to the Diagnostics & Research industry mean.
  • -6.3% Return on Equity means Genematrix generated ₩-0.06 for each ₩1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of GeneMatrix Inc:

  • The MRQ is -6.3%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -2.6%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-6.3%TTM-2.6%-3.8%
TTM-2.6%YOY-6.1%+3.5%
TTM-2.6%5Y-1.2%-1.4%
5Y-1.2%10Y-1.8%+0.6%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ-6.3%-0.4%-5.9%
TTM-2.6%-1.7%-0.9%
YOY-6.1%0.3%-6.4%
5Y-1.2%-0.9%-0.3%
10Y-1.8%-0.9%-0.9%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of GeneMatrix Inc.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Genematrix is operating .

  • Measures how much profit Genematrix makes for each ₩1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Genematrix to the Diagnostics & Research industry mean.
  • An Operating Margin of 0.0% means the company generated ₩0.00  for each ₩1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of GeneMatrix Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-2.3%+2.3%
5Y-2.3%10Y-12.2%+9.9%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ--9.6%+9.6%
TTM--12.4%+12.4%
YOY-2.6%-2.6%
5Y-2.3%1.4%-3.7%
10Y-12.2%4.1%-16.3%
4.3.2.2. Operating Ratio

Measures how efficient Genematrix is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Diagnostics & Research industry mean).
  • An Operation Ratio of 0.87 means that the operating costs are ₩0.87 for each ₩1 in net sales.

Let's take a look of the Operating Ratio trends of GeneMatrix Inc:

  • The MRQ is 0.867. The company is less efficient in keeping operating costs low.
  • The TTM is 1.520. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ0.867TTM1.520-0.653
TTM1.520YOY1.440+0.080
TTM1.5205Y0.945+0.575
5Y0.94510Y1.096-0.151
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ0.8671.311-0.444
TTM1.5201.294+0.226
YOY1.4401.266+0.174
5Y0.9451.208-0.263
10Y1.0961.191-0.095
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of GeneMatrix Inc.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Genematrix is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Diagnostics & Research industry mean).
  • A Current Ratio of 4.09 means the company has ₩4.09 in assets for each ₩1 in short-term debts.

Let's take a look of the Current Ratio trends of GeneMatrix Inc:

  • The MRQ is 4.086. The company is very able to pay all its short-term debts. +2
  • The TTM is 4.068. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ4.086TTM4.068+0.018
TTM4.068YOY4.370-0.302
TTM4.0685Y3.809+0.259
5Y3.80910Y2.506+1.304
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ4.0862.028+2.058
TTM4.0682.113+1.955
YOY4.3702.555+1.815
5Y3.8092.668+1.141
10Y2.5063.230-0.724
4.4.3.2. Quick Ratio

Measures if Genematrix is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Genematrix to the Diagnostics & Research industry mean.
  • A Quick Ratio of 0.00 means the company can pay off ₩0.00 for each ₩1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of GeneMatrix Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM2.098-2.098
TTM2.098YOY2.493-0.395
TTM2.0985Y2.842-0.744
5Y2.84210Y1.895+0.948
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ-1.206-1.206
TTM2.0981.241+0.857
YOY2.4931.685+0.808
5Y2.8422.100+0.742
10Y1.8952.428-0.533
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of GeneMatrix Inc.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Genematrix assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Genematrix to Diagnostics & Research industry mean.
  • A Debt to Asset Ratio of 0.30 means that Genematrix assets are financed with 30.2% credit (debt) and the remaining percentage (100% - 30.2%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of GeneMatrix Inc:

  • The MRQ is 0.302. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.281. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.302TTM0.281+0.022
TTM0.281YOY0.238+0.043
TTM0.2815Y0.247+0.034
5Y0.24710Y0.344-0.097
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3020.437-0.135
TTM0.2810.440-0.159
YOY0.2380.359-0.121
5Y0.2470.428-0.181
10Y0.3440.450-0.106
4.5.4.2. Debt to Equity Ratio

Measures if Genematrix is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Genematrix to the Diagnostics & Research industry mean.
  • A Debt to Equity ratio of 43.3% means that company has ₩0.43 debt for each ₩1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of GeneMatrix Inc:

  • The MRQ is 0.433. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.391. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.433TTM0.391+0.042
TTM0.391YOY0.313+0.078
TTM0.3915Y0.359+0.032
5Y0.35910Y0.663-0.304
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4330.640-0.207
TTM0.3910.686-0.295
YOY0.3130.502-0.189
5Y0.3590.666-0.307
10Y0.6630.712-0.049
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ₩1 in earnings Genematrix generates.

  • Above 15 is considered overpriced but always compare Genematrix to the Diagnostics & Research industry mean.
  • A PE ratio of -9.82 means the investor is paying ₩-9.82 for every ₩1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of GeneMatrix Inc:

  • The EOD is -10.988. Based on the earnings, the company is expensive. -2
  • The MRQ is -9.824. Based on the earnings, the company is expensive. -2
  • The TTM is -21.849. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-10.988MRQ-9.824-1.164
MRQ-9.824TTM-21.849+12.026
TTM-21.849YOY-18.358-3.492
TTM-21.8495Y6.390-28.240
5Y6.39010Y-6.251+12.642
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD-10.988-0.356-10.632
MRQ-9.824-0.693-9.131
TTM-21.849-0.881-20.968
YOY-18.358-0.145-18.213
5Y6.3901.937+4.453
10Y-6.2513.727-9.978
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of GeneMatrix Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM34.614-34.614
TTM34.614YOY-59.328+93.942
TTM34.6145Y-128.968+163.582
5Y-128.96810Y302.419-431.387
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ--1.088+1.088
TTM34.614-1.123+35.737
YOY-59.328-2.356-56.972
5Y-128.968-2.367-126.601
10Y302.419-2.248+304.667
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Genematrix is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Diagnostics & Research industry mean).
  • A PB ratio of 2.49 means the investor is paying ₩2.49 for each ₩1 in book value.

Let's take a look of the Price to Book Ratio trends of GeneMatrix Inc:

  • The EOD is 2.788. Based on the equity, the company is underpriced. +1
  • The MRQ is 2.493. Based on the equity, the company is underpriced. +1
  • The TTM is 2.591. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD2.788MRQ2.493+0.295
MRQ2.493TTM2.591-0.098
TTM2.591YOY3.301-0.710
TTM2.5915Y5.747-3.157
5Y5.74710Y6.554-0.806
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD2.7882.279+0.509
MRQ2.4932.309+0.184
TTM2.5912.317+0.274
YOY3.3012.384+0.917
5Y5.7473.753+1.994
10Y6.5544.539+2.015
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2023-06-302023-09-302023-12-312024-03-312024-06-30
Operating Income  -740,649568,427-172,222-351,119-523,341-391,033-914,3742,589,4901,675,116



6.2. Latest Balance Sheet

Balance Sheet of 2024-06-30. Currency in KRW. All numbers in thousands.

Summary
Total Assets28,585,895
Total Liabilities8,642,309
Total Stockholder Equity19,943,586
 As reported
Total Liabilities 8,642,309
Total Stockholder Equity+ 19,943,586
Total Assets = 28,585,895

Assets

Total Assets28,585,895
Total Current Assets19,255,175
Long-term Assets9,330,720
Total Current Assets
Total Current Assets  (as reported)19,255,175
Total Current Assets  (calculated)0
+/- 19,255,175
Long-term Assets
Long-term Assets  (as reported)9,330,720
Long-term Assets  (calculated)0
+/- 9,330,720

Liabilities & Shareholders' Equity

Total Current Liabilities4,712,027
Long-term Liabilities3,930,282
Total Stockholder Equity19,943,586
Total Current Liabilities
Total Current Liabilities  (as reported)4,712,027
Total Current Liabilities  (calculated)0
+/- 4,712,027
Long-term Liabilities
Long-term Liabilities  (as reported)3,930,282
Long-term Liabilities  (calculated)0
+/- 3,930,282
Total Stockholder Equity
Total Stockholder Equity (as reported)19,943,586
Total Stockholder Equity (calculated)0
+/- 19,943,586
Other
Common Stock Shares Outstanding 19,964
Net Working Capital 14,543,148



6.3. Balance Sheets Structured

Currency in KRW. All numbers in thousands.

 Trend2024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-31
> Total Assets 
20,053,077
20,445,802
20,159,594
19,676,768
19,217,387
18,295,418
17,902,745
17,050,445
16,833,415
16,544,643
21,338,067
20,781,912
20,364,235
20,052,838
19,685,418
19,333,902
19,041,199
18,432,196
18,149,097
17,743,477
27,159,006
26,103,944
25,387,806
31,518,643
30,819,589
30,339,812
28,958,734
28,455,836
27,795,311
31,917,139
33,478,360
38,167,716
39,225,396
41,474,339
41,758,211
39,532,094
36,190,522
35,028,841
34,518,527
31,902,312
30,717,075
29,707,686
32,461,435
31,353,937
29,673,361
28,585,895
28,585,89529,673,36131,353,93732,461,43529,707,68630,717,07531,902,31234,518,52735,028,84136,190,52239,532,09441,758,21141,474,33939,225,39638,167,71633,478,36031,917,13927,795,31128,455,83628,958,73430,339,81230,819,58931,518,64325,387,80626,103,94427,159,00617,743,47718,149,09718,432,19619,041,19919,333,90219,685,41820,052,83820,364,23520,781,91221,338,06716,544,64316,833,41517,050,44517,902,74518,295,41819,217,38719,676,76820,159,59420,445,80220,053,077
   > Total Current Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
11,721,568
11,442,703
11,080,946
20,535,782
19,535,615
18,613,109
19,136,478
18,481,973
17,803,232
16,237,925
15,766,975
15,202,775
17,669,993
19,277,265
19,062,224
20,061,919
19,485,013
20,055,954
21,112,639
23,084,282
22,318,618
22,446,648
21,279,576
20,239,814
19,561,972
21,011,524
19,404,566
18,927,714
19,255,175
19,255,17518,927,71419,404,56621,011,52419,561,97220,239,81421,279,57622,446,64822,318,61823,084,28221,112,63920,055,95419,485,01320,061,91919,062,22419,277,26517,669,99315,202,77515,766,97516,237,92517,803,23218,481,97319,136,47818,613,10919,535,61520,535,78211,080,94611,442,70311,721,56800000000000000000
       Cash And Cash Equivalents 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
880,938
1,442,331
1,262,785
10,461,947
9,682,996
8,401,362
5,373,569
5,510,017
3,667,128
2,252,219
5,974,863
4,115,905
4,075,823
6,009,588
9,203,007
10,303,929
10,173,782
11,550,001
5,271
5,119
4,736
6,318
3,535
3,975
3,778
3,719,273
2,169,613
2,388,396
0
02,388,3962,169,6133,719,2733,7783,9753,5356,3184,7365,1195,27111,550,00110,173,78210,303,9299,203,0076,009,5884,075,8234,115,9055,974,8632,252,2193,667,1285,510,0175,373,5698,401,3629,682,99610,461,9471,262,7851,442,331880,93800000000000000000
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
7,356,500
6,389,500
6,389,500
6,412,300
6,417,700
6,417,700
9,884,700
8,361,900
8,420,490
9,620,490
0
0
0
5,417,064
3,000,001
4,000,000
4,717,064
4,700,000
0
0
2,500,000
0
0
11,500,000
11,555,806
11,829,478
11,829,478
11,883,784
0
011,883,78411,829,47811,829,47811,555,80611,500,000002,500,000004,700,0004,717,0644,000,0003,000,0015,417,0640009,620,4908,420,4908,361,9009,884,7006,417,7006,417,7006,412,3006,389,5006,389,5007,356,50000000000000000000
       Net Receivables 
2,942,818
4,293,166
3,542,768
3,074,490
2,845,554
2,662,529
3,090,095
2,824,775
2,438,444
2,274,657
2,516,105
2,457,474
2,404,587
2,120,408
2,183,280
1,977,715
2,202,427
2,134,463
2,389,779
2,169,250
2,023,948
2,185,526
2,539,276
2,476,973
2,681,950
2,633,734
2,615,700
2,330,966
1,822,251
1,862,723
1,882,348
1,447,985
1,307,755
1,222,920
1,185,923
1,516,949
1,206,429
1,390,594
1,258,697
1,682,838
1,701,647
1,805,097
1,529,273
2,081,045
1,460,197
0
01,460,1972,081,0451,529,2731,805,0971,701,6471,682,8381,258,6971,390,5941,206,4291,516,9491,185,9231,222,9201,307,7551,447,9851,882,3481,862,7231,822,2512,330,9662,615,7002,633,7342,681,9502,476,9732,539,2762,185,5262,023,9482,169,2502,389,7792,134,4632,202,4271,977,7152,183,2802,120,4082,404,5872,457,4742,516,1052,274,6572,438,4442,824,7753,090,0952,662,5292,845,5543,074,4903,542,7684,293,1662,942,818
       Other Current Assets 
418,445
273,999
277,467
305,531
394,461
270,138
319,169
297,518
361,309
191,824
157,556
268,533
204,316
142,616
166,141
191,270
185,499
173,493
194,335
315,307
391,584
147,104
344,062
310,711
435,109
274,543
158,418
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000158,418274,543435,109310,711344,062147,104391,584315,307194,335173,493185,499191,270166,141142,616204,316268,533157,556191,824361,309297,518319,169270,138394,461305,531277,467273,999418,445
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
10,622,736
10,477,261
10,145,714
11,449,911
11,949,371
10,745,647
9,330,720
9,330,72010,745,64711,949,37111,449,91110,145,71410,477,26110,622,736000000000000000000000000000000000000000
       Property Plant Equipment 
7,543,877
7,428,221
7,337,930
7,258,802
7,255,197
7,240,747
7,178,832
7,018,918
6,947,483
6,867,436
6,816,111
6,732,752
6,874,700
6,781,805
6,699,740
6,661,717
6,596,920
6,588,743
6,589,301
6,551,746
6,513,451
6,458,836
6,670,676
6,605,446
6,564,987
6,573,375
6,233,136
6,193,663
6,102,591
6,127,329
6,060,104
6,318,258
6,381,322
6,326,269
6,276,660
6,167,607
6,063,522
6,341,228
6,375,571
6,325,472
6,301,837
6,304,490
6,263,526
6,441,973
6,337,528
0
06,337,5286,441,9736,263,5266,304,4906,301,8376,325,4726,375,5716,341,2286,063,5226,167,6076,276,6606,326,2696,381,3226,318,2586,060,1046,127,3296,102,5916,193,6636,233,1366,573,3756,564,9876,605,4466,670,6766,458,8366,513,4516,551,7466,589,3016,588,7436,596,9206,661,7176,699,7406,781,8056,874,7006,732,7526,816,1116,867,4366,947,4837,018,9187,178,8327,240,7477,255,1977,258,8027,337,9307,428,2217,543,877
       Goodwill 
308,453
0
0
308,453
308,453
0
0
308,453
0
0
0
86,115
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000000000000000086,115000308,45300308,453308,45300308,453
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
5,670,219
5,670,219
5,863,930
6,363,930
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000006,363,9305,863,9305,670,2195,670,21900000000000000000000000
       Intangible Assets 
668,414
650,336
626,379
636,312
610,364
620,727
596,771
563,456
538,334
515,204
482,572
216,215
208,077
199,795
189,800
110,695
100,783
96,222
91,430
85,123
82,400
80,636
75,163
79,364
75,275
72,140
99,523
94,262
89,009
83,755
104,929
86,154
80,563
77,772
72,191
65,482
60,543
75,693
94,419
90,215
82,056
75,912
69,929
64,227
62,280
0
062,28064,22769,92975,91282,05690,21594,41975,69360,54365,48272,19177,77280,56386,154104,92983,75589,00994,26299,52372,14075,27579,36475,16380,63682,40085,12391,43096,222100,783110,695189,800199,795208,077216,215482,572515,204538,334563,456596,771620,727610,364636,312626,379650,336668,414
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
75,179
0
0
0
65,778
0
0
0065,77800075,179000000000000000000000000000000000000000
> Total Liabilities 
6,351,368
6,993,104
6,923,263
6,897,249
6,931,472
6,107,924
5,684,518
5,162,492
5,363,647
5,655,395
10,861,398
10,744,743
10,816,498
10,911,735
8,150,034
5,731,873
5,974,913
5,620,583
5,787,570
5,798,348
16,097,449
15,571,280
15,695,204
20,121,445
15,088,526
15,464,027
14,159,842
13,206,468
11,643,206
7,106,820
5,460,446
4,775,069
5,097,379
5,071,469
5,523,367
7,211,197
7,829,635
6,989,948
7,249,042
7,716,615
7,573,625
7,538,279
8,980,543
8,205,695
8,373,788
8,642,309
8,642,3098,373,7888,205,6958,980,5437,538,2797,573,6257,716,6157,249,0426,989,9487,829,6357,211,1975,523,3675,071,4695,097,3794,775,0695,460,4467,106,82011,643,20613,206,46814,159,84215,464,02715,088,52620,121,44515,695,20415,571,28016,097,4495,798,3485,787,5705,620,5835,974,9135,731,8738,150,03410,911,73510,816,49810,744,74310,861,3985,655,3955,363,6475,162,4925,684,5186,107,9246,931,4726,897,2496,923,2636,993,1046,351,368
   > Total Current Liabilities 
1,593,328
2,466,142
2,386,394
6,324,240
6,298,998
5,506,669
5,137,365
4,633,119
4,772,548
5,065,172
5,197,731
5,118,372
5,176,059
5,099,874
7,558,621
5,154,998
5,377,320
4,969,708
5,074,582
5,025,483
5,174,319
4,568,533
4,566,291
15,006,777
9,881,959
10,148,494
8,047,414
12,044,116
10,460,628
6,279,764
4,598,945
4,081,883
4,316,097
4,405,283
4,783,986
5,343,443
5,728,082
4,712,482
4,807,565
5,006,383
4,668,996
4,629,618
5,799,954
4,519,236
4,433,001
4,712,027
4,712,0274,433,0014,519,2365,799,9544,629,6184,668,9965,006,3834,807,5654,712,4825,728,0825,343,4434,783,9864,405,2834,316,0974,081,8834,598,9456,279,76410,460,62812,044,1168,047,41410,148,4949,881,95915,006,7774,566,2914,568,5335,174,3195,025,4835,074,5824,969,7085,377,3205,154,9987,558,6215,099,8745,176,0595,118,3725,197,7315,065,1724,772,5484,633,1195,137,3655,506,6696,298,9986,324,2402,386,3942,466,1421,593,328
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
4,100,000
4,100,000
4,100,000
13,111,787
12,828,436
0
0
0
0
3,600,000
3,600,000
3,600,000
3,600,000
3,600,000
3,600,000
3,600,000
3,600,000
3,600,000
3,600,000
3,600,000
3,600,000
3,600,000
3,600,000
3,600,000
3,600,000
0
0
0
0
00003,600,0003,600,0003,600,0003,600,0003,600,0003,600,0003,600,0003,600,0003,600,0003,600,0003,600,0003,600,0003,600,0003,600,0003,600,0003,600,000000012,828,43613,111,7874,100,0004,100,0004,100,00000000000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
4,100,000
4,100,000
4,100,000
13,111,787
12,828,436
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3,600,000
3,600,000
3,600,000
3,600,000
3,600,000
3,600,000
0
03,600,0003,600,0003,600,0003,600,0003,600,0003,600,0000000000000000000012,828,43613,111,7874,100,0004,100,0004,100,00000000000000000000
       Accounts payable 
561,601
576,281
361,856
446,878
821,793
407,345
321,489
316,709
444,220
303,841
269,874
253,217
281,631
272,486
301,948
205,368
170,887
185,420
0
197,337
244,555
113,192
35,659
129,212
238,375
138,264
198,055
0
0
0
0
0
0
0
0
0
0
0
0
791,674
194,900
205,233
1,610,583
198,922
175,138
0
0175,138198,9221,610,583205,233194,900791,674000000000000198,055138,264238,375129,21235,659113,192244,555197,3370185,420170,887205,368301,948272,486281,631253,217269,874303,841444,220316,709321,489407,345821,793446,878361,856576,281561,601
       Other Current Liabilities 
1,031,727
1,733,332
1,924,538
1,672,649
1,212,912
987,882
1,088,335
616,410
628,328
661,331
827,857
765,155
794,428
727,388
1,246,252
849,630
1,106,433
684,288
974,582
728,146
829,764
536,212
665,063
1,623,501
1,132,258
1,334,393
1,121,666
0
0
0
0
0
0
0
0
0
0
0
0
-1
0
0
0
0
0
0
000000-10000000000001,121,6661,334,3931,132,2581,623,501665,063536,212829,764728,146974,582684,2881,106,433849,6301,246,252727,388794,428765,155827,857661,331628,328616,4101,088,335987,8821,212,9121,672,6491,924,5381,733,3321,031,727
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,710,231
2,904,629
2,908,662
3,180,589
3,686,459
3,940,786
3,930,282
3,930,2823,940,7863,686,4593,180,5892,908,6622,904,6292,710,231000000000000000000000000000000000000000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
35,747
0
0
0
35,949
0
27,446
39,536
33,836
28,099
22,329
17,883
14,168
11,230
0
0
0
0
0
0000011,23014,16817,88322,32928,09933,83639,53627,446035,94900035,747000000000000000000000000000
       Capital Lease Obligations Min Short Term Debt
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-4,100,000
-4,100,000
-4,100,000
-13,111,787
-12,828,436
0
0
0
0
-3,600,000
-3,600,000
-3,600,000
-3,600,000
-3,600,000
-3,600,000
-3,600,000
-3,600,000
-3,600,000
-3,600,000
-3,600,000
-3,600,000
-3,600,000
-3,554,096
-3,574,172
-3,540,722
71,336
160,491
147,707
0
0147,707160,49171,336-3,540,722-3,574,172-3,554,096-3,600,000-3,600,000-3,600,000-3,600,000-3,600,000-3,600,000-3,600,000-3,600,000-3,600,000-3,600,000-3,600,000-3,600,000-3,600,0000000-12,828,436-13,111,787-4,100,000-4,100,000-4,100,00000000000000000000
       Long-term Liabilities Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
0
0
1
1
0
0
0011001000000000000000000000000000000000000000
> Total Stockholder Equity
12,251,288
11,958,634
11,696,468
11,254,534
10,836,354
10,543,408
10,482,520
10,225,930
9,892,513
9,395,722
9,043,043
8,676,383
8,258,833
7,900,368
10,372,635
12,482,800
12,033,215
11,800,658
11,394,086
11,059,123
10,431,104
9,847,933
9,085,985
10,833,669
15,315,493
14,452,677
14,798,892
15,249,368
16,152,105
24,810,319
28,017,914
33,392,647
34,128,017
36,402,870
36,234,844
32,320,897
28,360,887
28,038,893
27,269,485
24,185,697
23,143,451
22,169,407
23,480,892
23,148,242
21,299,573
19,943,586
19,943,58621,299,57323,148,24223,480,89222,169,40723,143,45124,185,69727,269,48528,038,89328,360,88732,320,89736,234,84436,402,87034,128,01733,392,64728,017,91424,810,31916,152,10515,249,36814,798,89214,452,67715,315,49310,833,6699,085,9859,847,93310,431,10411,059,12311,394,08611,800,65812,033,21512,482,80010,372,6357,900,3688,258,8338,676,3839,043,0439,395,7229,892,51310,225,93010,482,52010,543,40810,836,35411,254,53411,696,46811,958,63412,251,288
   Common Stock
2,134,000
2,134,000
2,134,000
2,134,000
2,134,000
4,220,359
4,220,359
4,220,359
4,220,359
4,235,786
4,235,786
4,235,786
4,235,786
4,268,716
4,772,071
5,107,636
5,107,637
5,107,637
5,107,637
5,107,639
5,107,637
5,107,637
7,661,455
8,017,236
8,870,078
8,870,078
8,911,047
9,230,383
9,452,753
9,937,518
10,140,217
10,196,820
10,196,820
10,196,820
10,196,820
10,196,820
10,196,820
10,196,820
10,196,820
10,196,820
10,196,820
10,196,820
0
0
0
0
000010,196,82010,196,82010,196,82010,196,82010,196,82010,196,82010,196,82010,196,82010,196,82010,196,82010,196,82010,140,2179,937,5189,452,7539,230,3838,911,0478,870,0788,870,0788,017,2367,661,4555,107,6375,107,6375,107,6395,107,6375,107,6375,107,6375,107,6364,772,0714,268,7164,235,7864,235,7864,235,7864,235,7864,220,3594,220,3594,220,3594,220,3592,134,0002,134,0002,134,0002,134,0002,134,000
   Retained Earnings 
294,470
0
425,322
497,161
572,893
538,118
0
640,759
0
657,815
0
521,178
521,178
0
426,405
426,406
0
426,406
-10,500,466
426,406
-11,677,311
-12,220,523
-12,962,758
-14,014,070
-14,829,661
-15,221,959
-15,226,749
-15,462,437
-15,369,144
-9,825,827
-8,074,633
-7,454,174
-6,725,576
-4,443,762
-4,618,311
-8,525,924
-12,405,358
-12,720,224
-13,482,505
-16,661,123
-17,607,223
-18,581,267
-17,365,929
-17,698,579
-19,308,583
0
0-19,308,583-17,698,579-17,365,929-18,581,267-17,607,223-16,661,123-13,482,505-12,720,224-12,405,358-8,525,924-4,618,311-4,443,762-6,725,576-7,454,174-8,074,633-9,825,827-15,369,144-15,462,437-15,226,749-15,221,959-14,829,661-14,014,070-12,962,758-12,220,523-11,677,311426,406-10,500,466426,4060426,406426,4050521,178521,1780657,8150640,7590538,118572,893497,161425,3220294,470
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
20,524,129
21,709,750
22,263,390
24,893,225
26,145,511
30,878,328
30,878,328
30,878,328
30,878,328
30,878,328
30,878,328
30,878,328
30,878,328
30,878,328
30,878,328
30,878,328
0
0
0
0
000030,878,32830,878,32830,878,32830,878,32830,878,32830,878,32830,878,32830,878,32830,878,32830,878,32830,878,32826,145,51124,893,22522,263,39021,709,75020,524,12900000000000000000000000000
   Treasury Stock0000000000-1,621-1,621-1,621-1,621-1,621-1,621-1,621-1,621-1,6210000000000000000-486,853-486,853-486,853-486,853-486,853-486,853-486,853-486,853-486,853-486,853-387,379
   Other Stockholders Equity 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
426,405
426,405
426,406
640,268
600,309
600,310
600,310
699,450
600,310
697,144
-226,707
-226,706
-226,706
-226,706
-226,707
-226,706
-226,706
-226,706
-226,707
-226,706
-226,706
-226,706
-226,707
-226,706
-226,706
0
0
0
0
0000-226,706-226,706-226,707-226,706-226,706-226,706-226,707-226,706-226,706-226,706-226,707-226,706-226,706-226,706-226,707697,144600,310699,450600,310600,310600,309640,268426,406426,405426,40500000000000000000



6.4. Balance Sheets

Currency in KRW. All numbers in thousands.




6.5. Cash Flows

Currency in KRW. All numbers in thousands.




6.6. Income Statements

Currency in KRW. All numbers in thousands.


6.7. Latest Income Statement

Income Statement (annual), 2023-12-31. Currency in KRW. All numbers in thousands.

Gross Profit (+$)
totalRevenue9,814,503
Cost of Revenue-4,910,158
Gross Profit4,904,3454,904,345
 
Operating Income (+$)
Gross Profit4,904,345
Operating Expense-12,362,542
Operating Income-2,548,039-7,458,197
 
Operating Expense (+$)
Research Development3,465,693
Selling General Administrative1,452,897
Selling And Marketing Expenses0
Operating Expense12,362,5424,918,590
 
Net Interest Income (+$)
Interest Income427,350
Interest Expense-138,039
Other Finance Cost-1
Net Interest Income289,310
 
Pretax Income (+$)
Operating Income-2,548,039
Net Interest Income289,310
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-894,938-2,548,039
EBIT - interestExpense = -138,039
-894,938
-756,899
Interest Expense138,039
Earnings Before Interest and Taxes (EBIT)0-756,899
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax-894,938
Tax Provision-0
Net Income From Continuing Ops-894,938-894,938
Net Income-894,938
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net0-289,310
 

Technical Analysis of Genematrix
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Genematrix. The general trend of Genematrix is BEARISH with 14.3% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Genematrix's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-14.3%) Bearish trend (14.3%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of GeneMatrix Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 3,640 < 3,990 < 4,295.

The bearish price targets are: 2,660 > 2,645 > 2,585.

Tweet this
GeneMatrix Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of GeneMatrix Inc. The current mas is .

The long score for the Moving Averages is 6/14.
The longshort score for the Moving Averages is -2/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

GeneMatrix Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of GeneMatrix Inc. The current macd is -149.6650318.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Genematrix price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Genematrix. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Genematrix price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
GeneMatrix Inc Daily Moving Average Convergence/Divergence (MACD) ChartGeneMatrix Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of GeneMatrix Inc. The current adx is 13.95.

The long score for the Directional Movement Index (DMI) is 1/7.
The longshort score for the Directional Movement Index (DMI) is 1/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Genematrix shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
GeneMatrix Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of GeneMatrix Inc. The current sar is 2,719.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
GeneMatrix Inc Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of GeneMatrix Inc. The current rsi is 39.07. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending down: The RSI is trending down. -1
GeneMatrix Inc Daily Relative Strength Index (RSI) ChartGeneMatrix Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of GeneMatrix Inc. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -6/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Genematrix price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
GeneMatrix Inc Daily Stochastic Oscillator ChartGeneMatrix Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of GeneMatrix Inc. The current cci is -98.18548387.

GeneMatrix Inc Daily Commodity Channel Index (CCI) ChartGeneMatrix Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of GeneMatrix Inc. The current cmo is -28.31813238.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
GeneMatrix Inc Daily Chande Momentum Oscillator (CMO) ChartGeneMatrix Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of GeneMatrix Inc. The current willr is -87.24489796.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
GeneMatrix Inc Daily Williams %R ChartGeneMatrix Inc Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of GeneMatrix Inc.

GeneMatrix Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of GeneMatrix Inc. The current atr is 228.39.

GeneMatrix Inc Daily Average True Range (ATR) ChartGeneMatrix Inc Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of GeneMatrix Inc. The current obv is 118,713,697.

GeneMatrix Inc Daily On-Balance Volume (OBV) ChartGeneMatrix Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of GeneMatrix Inc. The current mfi is 66.89.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
GeneMatrix Inc Daily Money Flow Index (MFI) ChartGeneMatrix Inc Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for GeneMatrix Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-06-27MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-06-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-04STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-07-09MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-07-11STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-07-12MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-07-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-17MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-07-18STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-07-19MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-07-23BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-07-24STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-25STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-07-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-29SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-07-30MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-07-31CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-08-02CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-08-05RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-08-06STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-07ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-08-08ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-09STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-13RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-08-14SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-08-16STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-08-19SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-08-20STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-22RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-08-26SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-08-27MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-08-29WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-09-04STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-05STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-09-06DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-09-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-10MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-09-13DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-09-19DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-09-20STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-24DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-09-26MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-27STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-09-30STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-08STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-10-14STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-15SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-10-16CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-10-18STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-10-21STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-22CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-10-23MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-10-24STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-25STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-10-28STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-30STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-10-31CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-11-01DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-11-04DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-05SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-11-06SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-07CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-11-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-12DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-13STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-18DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-11-20STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-21STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-22STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside

6.3. Candlestick Patterns

GeneMatrix Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of GeneMatrix Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5039.069
Ma 20Greater thanMa 503,040.000
Ma 50Greater thanMa 1003,216.800
Ma 100Greater thanMa 2003,190.900
OpenGreater thanClose2,850.000
Total3/5 (60.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Genematrix with someone you think should read this too:
  • Are you bullish or bearish on Genematrix? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Genematrix? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about GeneMatrix Inc

I send you an email if I find something interesting about GeneMatrix Inc.


Comments

How you think about this?

Leave a comment

Stay informed about GeneMatrix Inc.

Receive notifications about GeneMatrix Inc in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.